Neurodegeneration
How tau buildup shapes brain networks in dementia
Open access · cc by · source: Europe PMC
In Alzheimer's disease, tau builds up in highly connected brain hubs and weakens their connections, while in progressive supranuclear palsy, tau accumulates in deep brain structures and forces the cortex to use less efficient, indirect pathways.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Tau tends to sit in network hubs and tracks weaker cortical connectivity in AD.
In Alzheimer’s disease, tau PET burden concentrated in highly connected cortical hubs and higher overall tau associated with weakened cortical connection strength; progressive-supranuclear-palsy patterns differed, showing disease-specific mapping of tau onto networks.
Evidence for the claim as stated.
Pathogenic tau can sit in retinal ganglion cells in MCI and AD, with substantial RGC loss.
In 41 donor eyes, MCI-due-to-AD and AD retinas showed pS396-tau and oligomeric tau inside RGCs, hypertrophic somas and death-pathway markers, about 50% RGC loss, and correlations with brain AD pathology, stage, and cognition.
Scope note — in vivo cortical tau PET connectome — not retinal histology
Limits the claim's scope: a different population, assay, or outcome.
In Alzheimer's disease, tau pathology targets highly connected hub regions and degrades cortical connection strength, whereas in progressive supranuclear palsy, tau accumulates in deep structures and forces the cortex to use less efficient, indirect pathways.
Evidence for the claim as stated.
History
When this study was placed
Dated entries from the concept change log — when this paper was added or removed as support, challenge, or qualifier on a claim.
Placed as a scope qualifier on Alzheimer’s and MCI markers
In 41 donor eyes, MCI-due-to-AD and AD retinas showed pS396-tau and oligomeric tau inside RGCs, hypertrophic somas and death-pathway markers, about 50% RGC loss, and correlations with brain AD pathology, stage, and cognition.
Discoveries this paper informs or conflicts with
- The same protein accumulates in hub regions in one disease and deep structures in another
This paper informs this development.
Study at a glance
- Design
- Case-control — Tau PET and functional connectome in Alzheimer's disease vs progressive supranuclear palsy
- N
- N=34 · 17 AD and 17 PSP
- Population
- Patients with Alzheimer's disease or progressive supranuclear palsy who had capacity to consent
- Outcome
- Relationship of tau burden to the functional connectome in AD versus PSP
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
How tau buildup shapes brain networks in dementia
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
17 patients with Alzheimer's disease
We recruited 17 patients with Alzheimer’s disease, as evidenced by a either clinical diagnosis of probable Alzheimer’s dementia according to consensus criteria ( n = 10) (), or a clinical diagnosis of mild cognitive impairment (MCI) and a positive amyloid PET scan ( n = 7) (; ).
17 patients with progressive supranuclear palsy
We also recruited 17 patients with PSP-Richardson’s syndrome by 1996 criteria ().
Key findings
In patients with Alzheimer's disease, tau primarily accumulated in highly connected hub regions (r = 0.48), and a higher overall tau burden correlated with weakened cortical connection strength (r = -0.58). In contrast, progressive supranuclear palsy patients accumulated tau in deep brain structures, which did not track connectivity hubs but correlated with an increase in cortical-to-cortical connection strength (r = 0.65). These distinct patterns suggest that Alzheimer's tau spreads through active functional networks, whereas progressive supranuclear palsy tau follows regional metabolic or trophic vulnerabilities.
Methodology
The researchers measured tau protein buildup and resting-state functional brain connectivity in 17 patients with Alzheimer's disease, 17 patients with progressive supranuclear palsy, and 12 age-matched healthy controls. They used a tau PET ligand to quantify the amount of tau burden in different brain regions. To assess brain connectivity, participants completed 11 minutes of resting-state functional magnetic resonance imaging, which tracked how different brain areas synchronized their activity.
Limitations
Because the study design was cross-sectional rather than longitudinal, it cannot prove that tau spreads along functional connections over time or that connectivity changes are directly caused by tau accumulation. The PET imaging ligand primarily binds to aggregated tau tangles and cannot detect toxic, non-aggregated oligomeric tau forms. Additionally, the small cohort sizes (17 patients per disease group and 12 controls) limit the statistical power and generalizability of the findings. Finally, functional MRI has lower signal sensitivity in the deep subcortical brain areas where progressive supranuclear palsy pathology is concentrated.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- How does brain structure change in early Parkinson's disease?
- How does brain inflammation affect connectivity and thinking in AD?
- Can a new PET imaging tracer distinguish different tau diseases?
- Does brain region loss predict memory decline in Parkinson's?
- Using Brain Scans to Predict Cognitive Decline in Alzheimer's